Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study

Background A recombinant vesicular stomatitis virus vector expressing the Zaire Ebola virus glycoprotein (rVSVΔG-ZEBOV-GP) vaccine has been reported as safe, immunogenic, and highly protective in a ring vaccination trial. We aimed to identify transcriptomic immune response biomarker signatures induc...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Vianello, E, Gonzalez-Dias, P, van Veen, S, Engele, CG, Quinten, E, Monath, TP, Medaglini, D, Agnandij, ST, Ahmed, R, Anderson, J, Auderset, F, Bejon, P, Borgianni, L, Brosnahan, J, Ciabattini, A, Engler, O, Haks, MC, Harandi, AM, Heppner, DG, Gerlini, A, Huttner, A, Kremsner, PG, Ndungu, FM, Njuguna, P, Ottenhoff, THM, Pejoski, D, Page, M, Pozzi, G, Santoro, F, Siegrist, CA, Dubey, S, Eichberg, M, Ndong, EP, Lumeka, K, Nakaya, HI, Gonzales Dias Carvalho, P, Rothenberger, S, Nakka, SS, Essone, PN, Agnandji, ST
פורמט:	Journal article
שפה:	English
יצא לאור:	Elsevier 2021

Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study

פריטים דומים